Press release -

Enzymaticas veterinary products launched at the AVMA Annual Convention in Denver, USA

Enzymatica, which develops and sells products based on enzyme from deep-sea cod, today announces that its new veterinary products will be presented at the AVMA Annual Convention in Denver, USA on July 25-29 2014. The launch is through Enzymatica’s U.S. distributor Adartis Animal Health.

The products, Kalvatin® Dermal and Kalvatin® Dental, are enzyme-based products against skin and gum infections. The products’ target audience is veterinary clinics primarily for dogs, cats and horses.

- The Kalvatin products are an innovative addition to our product offering and part of our focus on international markets. We look forward to following our distributor's activities in the market during the coming fall and winter. Marketing has just started and is still in the development phase, says Michael Edelborg Christensen, CEO of Enzymatica.

The development of veterinary products has been on the same technology platform used in Enzymaticas common cold product ColdZyme®. As animal pathogens and human pathogens are similar, the corresponding barrier-building system developed for human indications can also be used to treat animals.

Sales to veterinary clinics in North America will be through the U.S. distributor Adartis Animal Health, who is also responsible for product marketing activities. To support the distributor, Enzymatica has established a subsidiary, Enzymatica North America Inc.

U.S. is the biggest market for veterinary products. In the U.S., about two-thirds of the households have pets, where dogs and cats are the most common animals. The number of veterinary clinics amounts to approximately 44, 000.*

The organization behind the exhibition is the American Veterinary Medical Association (AVMA) with approximately 85,000 veterinarians and veterinary students as members.

For more information, please contact:
Michael Edelborg Christensen, CEO Enzymatica AB (publ) 
Phone: +46 768 14 41 66. E-mail: michael.christensen@enzymatica.se

For more information about Adartis Animal Health and the Kalvatin® products, please visit: www.adartisanimalhealth.com www.kalvatin.com

* American Pet Products Associations website 2014.

Topics

  • Economy, Finance

About Enzymatica AB (publ)
Enzymatica AB (publ) develops and sells medical technology products based on an enzyme from deep-sea cod. Our development includes medical devices in upper respiratory infections and oral health, and veterinary products in oral health and dermatology. Its launched medical portfolio includes ColdZyme® CE Mouth spray for colds, available at the Swedish pharmacy market since 2013. It is headquartered in Lund, Sweden and is listed on Aktietorget. For more information, please visit www.enzymatica.se. 

Contacts

Fredrik Lindberg

Press contact CEO +46 (0)708-86 53 70